Holen Sie sich die Stockscreener-App
4.01
0.75%
0.03
Finanzdaten der Larimar Therapeutics Inc-Aktie (LRMR)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
18.16%
16.73
|
14.16 | 10.34 | 9.62 | 7.637 |
| Operating Income/Loss |
18.16%
-16.73
|
-14.16 | -10.34 | -9.62 | -7.637 |
| Nonoperating Income/Loss |
77.93%
2.08
|
1.169 | 1.275 | 1.254 | 1.111 |
| Income/Loss From Continuing Operations Before Tax |
12.78%
-14.65
|
-12.99 | -9.064 | -8.366 | -6.526 |
| Income/Loss From Continuing Operations After Tax |
12.78%
-14.65
|
-12.99 | -9.064 | -8.366 | -6.526 |
|
Net Income/Loss
|
12.78%
-14.65
|
-12.99 | -9.064 | -8.366 | -6.526 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
3.41M%
53.55
|
0.00157 | 43.90 | 43.90 | 43.90 |
| Diluted Average Shares |
3.41M%
53.55
|
0.00157 | 43.90 | 43.90 | 43.90 |
| Basic Earnings Per Share |
6.90%
-0.27
|
-0.29 | -0.21 | -0.19 | -0.15 |
| Diluted Earnings Per Share |
6.90%
-0.27
|
-0.29 | -0.21 | -0.19 | -0.15 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.88%
2.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):